Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Gastroenterology
Published in: Journal of Gastroenterology 10/2001

01-10-2001

Expression of Fas/Fas ligand (FasL) and its involvement in infiltrating lymphocytes in hepatocellular carcinoma (HCC)

Authors: Yoshitaka Fukuzawa, Kiyoshi Takahashi, Keiko Furuta, Tsuneaki Tagaya, Tetsuya Ishikawa, Kaori Wada, Yasukazu Omoto, Takehiko Koji, Shinichi Kakumu

Published in: Journal of Gastroenterology | Issue 10/2001

Login to get access
Metadata
Title
Expression of Fas/Fas ligand (FasL) and its involvement in infiltrating lymphocytes in hepatocellular carcinoma (HCC)
Authors
Yoshitaka Fukuzawa
Kiyoshi Takahashi
Keiko Furuta
Tsuneaki Tagaya
Tetsuya Ishikawa
Kaori Wada
Yasukazu Omoto
Takehiko Koji
Shinichi Kakumu
Publication date
01-10-2001
Publisher
Springer-Verlag
Published in
Journal of Gastroenterology / Issue 10/2001
Print ISSN: 0944-1174
Electronic ISSN: 1435-5922
DOI
https://doi.org/10.1007/s005350170031

Other articles of this Issue 10/2001

Journal of Gastroenterology 10/2001 Go to the issue

OriginalPaper

Risk factors for lymph node metastasis of submucosal invasive differentiated type gastric carcinoma: clinical significance of histological heterogeneity

Review

Hepatitis B virus X protein: a multifunctional viral regulator

Case report

Multiple early gastric cancer associated with sarcoid-like reaction in the regional lymph nodes

OriginalPaper

Medium-chain triglyceride-rich enteral nutrition is more effective than low-fat enteral nutrition in rat colitis, but is equal in enteritis

Editorial

Fas and Fas ligand in human hepatocellular carcinoma

OriginalPaper

Genetic differences in CYP2C19 single nucleotide polymorphisms among four Asian populations
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits